Can Fite Biopharma stock hits 52-week low at $1.22

1 week ago 9
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. Can Fite Biopharma stock hits 52-week low at $1.22

Related

Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research (AACR) Annual Meeting

Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA ...

2 hours ago 0
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology

Abbott Highlights New AVEIR™ Data, Initiates Trial for the C...

3 hours ago 2
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager

Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P...

3 hours ago 2
RIGHT SIDEBAR TOP AD

Trending

Popular

What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

2 weeks ago 79
Paxton's challenge isn't the only one worrying Senate Republicans

Paxton's challenge isn't the only one worrying Senate Republ...

2 weeks ago 78
Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds slim Masters lead at midway point

Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds sli...

2 weeks ago 68
Biden reemerges on the attack, but doesn’t mention Trump

Biden reemerges on the attack, but doesn’t mention Trump

1 week ago 67
From classifying immigrants as dead to deportation: A guide to actions on Trump immigration policies

From classifying immigrants as dead to deportation: A guide ...

2 weeks ago 66
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved